Greenberg Traurig’s Special Purpose Acquisition Companies (SPACs) Practice regularly represents underwriters, targets, and sponsors of SPACs (and related UK Shells), and the SPACs themselves, in a number of initial public offerings (IPOs), including on the NYSE, London Stock Exchange, and other major stock markets, as well as in subsequent business combinations and acquisitions. Since 2011, our attorneys have represented issuers and underwriters in over 50 IPOs with an aggregate value of approximately $14 billion. In the last 10 years, our attorneys have represented SPACs and their successor companies in M&A transactions with an aggregate value of over $70 billion, including matters in the food and beverage, chemicals, waste management, telecommunications, and media sectors. Our experience and knowledge is recognized by SPAC Research, where we are ranked second on its DeSPAC legal advisors table for business combinations in 2021 (based on closed and pending deals).
We have a thorough understanding of the SPAC process and we regularly counsel our SPAC clients on:
- the IPO process, including offerings made through Rule 144A or Regulation S;
- potential jurisdictions for the incorporation of their company, how to structure the offering, and the make-up of the management team and outside directors; and
- once the IPO is effective, the identification of target companies and the consummation of business combinations, effectively taking target companies public.
To learn more about our Special Purpose Acquisition Companies (SPACs) capabilities, please feel free to reach out to our Special Purpose Acquisitions Companies (SPACs) Practice Contacts.